SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Max Healthcare rises as its arm executes sale deed for acquisition of land and building in UP

19 May 2025 Evaluate

Max Healthcare Institute is currently trading at Rs. 1186.30, up by 19.75 points or 1.69% from its previous closing of Rs. 1166.55 on the BSE.

The scrip opened at Rs. 1181.15 and has touched a high and low of Rs. 1190.45 and Rs. 1168.80 respectively. So far 17274 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1227.50 on 08-Jan-2025 and a 52 week low of Rs. 743.00 on 31-May-2024.

Last one week high and low of the scrip stood at Rs. 1204.00 and Rs. 1132.25 respectively. The current market cap of the company is Rs. 115461.88 crore.

The promoters holding in the company stood at 23.74%, while Institutions and Non-Institutions held 72.32% and 3.94% respectively.

Max Healthcare Institute’s wholly-owned subsidiary -- Crosslay Remedies (CRL) has executed a sale deed for the acquisition of 4,000 sq. meters land parcel, along with the building thereon, located adjacent to Max Super Speciality Hospital (MSSH), Vaishali, Uttar Pradesh (UP), at a consideration of around Rs 120 crore. This strategic acquisition paves the way for the addition of around 140 beds at MSSH, Vaishali over period of next 30 months, significantly enhancing CRL’s capacity to serve the growing healthcare needs of the region.

Max Healthcare Institute offers healthcare services through its various facilities in Delhi and the National Capital Region, and facilities in Mohali and Bathinda.

Max Healthcare Inst Share Price

1006.90 16.05 (1.62%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×